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The lateral hypothalamus (LH) is a key regulator of multiple vital behaviors. The firing of brain-wide-projecting LH neurons releases
neuropeptides promoting wakefulness (orexin/hypocretin; OH), or sleep (melanin-concentrating hormone; MCH). OH neurons, which
coexpress glutamate and dynorphin, have been proposed to excite their neighbors, including MCH neurons, suggesting that LH may
sometimes coengage its antagonistic outputs. However, it remains unclear if, when, and how OH actions promote temporal separation of
the sleep and wake signals, a process that fails in narcolepsy caused by OH loss. To explore this directly, we paired optogenetic stimulation
of OH cells (at rates that promoted awakening in vivo) with electrical monitoring of MCH cells in mouse brain slices. Membrane potential
recordings showed that OH cell firing inhibited action potential firing in most MCH neurons, an effect that required GABAA but not
dynorphin receptors. Membrane current analysis showed that OH cell firing increased the frequency of fast GABAergic currents in MCH
cells, an effect blocked by antagonists of OH but not dynorphin or glutamate receptors, and mimicked by bath-applied OH peptide. In
turn, neural network imaging with a calcium indicator genetically targeted to MCH neurons showed that excitation by bath-applied OH
peptides occurs in a minority of MCH cells. Collectively, our data provide functional microcircuit evidence that intra-LH feedforward
loops may facilitate appropriate switching between sleep and wake signals, potentially preventing sleep disorders.
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Introduction
The lateral hypothalamus (LH), historically seen as a vital source
of wakefulness signals, is now known to coordinate arousal, sleep,
and energy balance (Sakurai, 2002; Saper et al., 2005; de Lecea,
2012; Jego and Adamantidis, 2013). It contains a heterogeneous
population of neurons, including those expressing the neuropep-
tides orexin/hypocretin (OH) or melanin-concentrating hor-
mone (MCH), both of which send wide projections throughout
the brain (Bittencourt et al., 1992; Trivedi et al., 1998). In several
respects, OH and MCH neurons exert antagonistic actions on
brain state and energy balance. Deletion of OH causes inappro-
priate sleepiness (narcolepsy) and weight gain (Chemelli et al.,
1999; Hara et al., 2001), whereas deletion of MCH or the MCH
receptor 1 results in increased hyperactivity and leanness (Shi-
mada et al., 1998; Marsh et al., 2002; Takase et al., 2014). OH cell
activation produces awakening (Adamantidis et al., 2007),
whereas MCH cell activation promotes REM sleep (Jego et al.,
2013; Tsunematsu et al., 2014). Chronic activation of MCH cells
randomly and independently of sleep state can also increase
NREM sleep (Jego and Adamantidis, 2013; Konadhode et al.,
2013).
In vivo recordings suggest that MCH neurons fire during REM
sleep, whereas OH neurons fire during wakefulness (Hassani et
al., 2009). However, bath application of OH peptides can excite
MCH neurons in vitro (van den Pol et al., 2004; Li and van den
Pol, 2006). Hypothetically, these apparently contradictory obser-
vations could be reconciled if OH cell activity had a dual effect on
the MCH network. For example, excitation of some MCH cells by
OH may result in coactivation of antagonist signals, which is
considered useful for fine control in some systems (Smith, 1981;
Baratta et al., 1988; Cui et al., 2013: Tecuapetla et al., 2014).
Concurrently, OH-dependent wakefulness would be protected
from sleep intrusions if most MCH neurons were inhibited by
OH cell firing, through as yet unidentified circuits. These hypoth-
eses can be directly investigated by recording from MCH cells
during OH cell firing, and by examining OH peptide effects at the
level of MCH cell network. Recent technological advances allow
the latter to be assessed by network-level calcium imaging (Chen
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et al., 2013), and the former by optogenetics-assisted circuit anal-
ysis (Petreanu et al., 2007). Here we apply both of these tools to
explore how OH cell activity influences MCH neurons.
Materials and Methods
Gene transfer. Animal procedures followed United Kingdom Home Of-
fice regulations. AAV constructs carrying channelrhodopsin-2 (ChR2)
and lentiviruses expressing mCherry under the control of MCH pro-
moter were bilaterally stereotactically coinjected into the LH of
orexin-cre mice of either sex (Matsuki et al., 2009; Sasaki et al., 2011).
This targets ChR2 expression to OH neurons (Schöne et al., 2012). To
target expression of mCherry to MCH neurons, we used a lentiviral
vector carrying the 0.9 kb preproMCH gene promoter. The specificity
of lentivirus-mediated expression was tested by stereotactic delivery of
MCH::mCherry lentiviral vector (10 9 pfu/ml) into the LH of
MCH::eGFP transgenic mice (Stanley et al., 2010), and confirmed by
staining with MCH antibody (see Fig. 2). The MCH::mCherry lentivirus
used in this study was generated by Penn Vector Core, University of
Pennsylvania (VSVG.HIV.MCH.mCherry(p2428), titer 3.16  10 11 gc/
ml. AAV vectors delivering ChR2 were also produced by the Penn
Vector Core; we used AAV2-EF1a-DIO-ChR2(E123T/T159C)-eYFP
or AAV1.EF1a.DIO.hChR2(H134R)-eYFP.WPRE.hGH. The titers of
ChR2-AAVs were 1.4  10 13 gc/ml. Three 100 nl injections of the
mixed viruses were made at: 1.3 to 1.4 mm from bregma; 0.9 mm
from midline; and 5.30, 5.15, and 5.00 mm from skull surface.
For calcium imaging, AAV carrying cre-dependent GCaMP6s
(rAAV9.CAG.Flex.GCaMP6s.WPRE.SV40; Penn Vector Core, lot
CS0419, titer 2.74  10 13 gc/ml) was bilaterally stereotaxically injected
into LH of MCH-cre mice (Kong et al., 2010). Three 50 nl injections of
the GCaMP6s virus were at: 1.35 mm from bregma; 0.9 mm from
midline; and 5.30, 5.20, and 5.10 mm from brain surface. To con-
firm the selectivity of the Tg(Pmch-Cre) transgenic mice, animals were
crossed with cre-dependent TdTomato reporter (Rosa-CAG-LSL-
tdTomato-WPRE, line Ai9, Jackson Laboratories) and immunostained
for MCH. 85.87  1.41% of MCH-immunopositive cells were found to
express TdTomato, whereas 99.81  0.09% of TdTomato cells expressed
MCH (2432 cells, n  3 mice). GCaMP6s fluorescence was not seen after
the AAV coding for GCaMP6s was injected into the LH of wild-type mice
(n  3 mice), confirming that it was selective to cre-containing neurons.
Calcium imaging, electrophysiology, and photostimulation. Four to six
weeks after stereotactic injections, acute brain slices were prepared as in
our previous work (Schöne et al., 2012). Mice were maintained on a
standard 12 h light/dark cycle, and slice recordings performed in both the
light (11:00 A.M. to 6:00 P.M.) and dark (6:00 P.M. to 9:00 P.M.) parts of
the cycle, with similar results. For calcium imaging, brain slices were
placed in a recording chamber of an upright microscope (BX61WI,
Olympus) controlled by the Olympus Fluoview software (FV10-ASW ver
4.0), and perfused at 35°C with ACSF. Confocal imaging was performed
at 4 Hz frame-rate through an Olympus 20 0.50 NA objective, with a
488 nm Argon laser excitation, and 500 –545 nm spectral detector emis-
sion collection. Movies were motion-corrected (StackReg plugin, ImageJ).
A region of-interest (ROI) around each GCaMP6s-positive cell body was
selected using the ROI manager in ImageJ. The ROI locations were used to
extract the mean fluorescence value for each object on each frame F(t). To
correct for background activity and normalize for the fluorescence value of
each cell, we first separated experimental trials into two parts: a baseline
period corresponding to all the frames recorded before one frame after the
presentation of orexin, and a stimulus period, beginning 4 s after the onset of
orexin application and lasting 10 min. Next, for each ROI we calculated
%dF/F for each frame (t), where dF/F  (F(t)  F) *100/F, and F was the
mean fluorescence value for that ROI for all frames in the baseline period for
that trial. For whole-cell patch-clamp recordings, performed and analyzed as
in our previous work (Schöne et al., 2012), MCH cells were visualized in
acute living brain slices using a mCherry filter set (Chroma). To stimulate
ChR2, we used a Thorlabs blue LED, delivering 10 mW/mm2 light to
ChR2-containing axons around the recorded cell through a 40 0.8 NA
objective. Whole-cell recordings were performed at 37°C using an EPC-10
amplifier and Patch-Master software (HEKA Elektronik). Averaged data are
presented as the mean  SEM. Statistical significance was evaluated using
ANOVA with Bonferonni post-test, unless stated otherwise.
Chemicals and solutions. Slice-cutting and recording ACSF was gassed
with 95% O2 and 5% CO2, and contained the following (mM): 125 NaCl,
Figure 1. Responses of MCH neurons to bath-applied orexin peptide. A, Summary of intracellular calcium responses of individual MCH neurons to 1 M bath-applied orexin-A (A1; n  42 cells).
Traces show examples of excitation (green), inhibition (red), and no response (black). A2, A3, Confirmation of localization of GCaMP6s calcium indicator to MCH neurons (see Materials and Methods).
Scale bar, 80 m. B, Effect of bath applied orexin-A on MCH cell membrane potential; typical example (B1) and group data (B2).
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25 NaHCO3, 3 KCl, 1.25 NaH2PO4, 1/2 CaCl2 (cutting/recording), 6/1
MgCl2 (cutting/recording), 3 sodium pyruvate, and 25/5 glucose (cut-
ting/recording). Pipettes were filled with (in mM): 135 potassium glu-
conate, 7 NaCl, 10 HEPES, 2 Na2-ATP, 0.3 Na-GTP, and 2 MgCl2; pH
was adjusted to 7.3 with KOH. Drug concentrations were (in m): 20
CNQX and 100 AP5, 10 gabazine, 1 TTX, 5 nor-binaltorphimine dihy-
drochloride (nor-BNI), 10 SB-334867 (SB), and 10 TCS-OX2–29 (TCS).
All chemicals were from Signal, Tocris Bioscience, or Bachem.
Immunocytochemistry. Primary antibodies were as follows: goat anti-
orx-B (1:1000; Santa Cruz Biotechnology), rabbit anti-GABA (1:500;
Immunostar), and rabbit anti-MCH (1:1000, Phoenix Pharmaceuticals)
Secondary antibodies were AlexaFluor 594 donkey anti-rabbit and Alex-
aFluor 488 donkey anti-goat (both 1:1000; Thermo Fisher). Orexin,
MCH, and biocytin immunostaining was performed as in our previous
work (Burdakov et al., 2005). For GABA immunostaining, tissue was
heated to 80°C for 30 min in sodium citrate (pH 8; Sigma-Aldrich),
washed in 0.1 M PBS, treated three times for 5 min in sodium borohydride
solution (1 mg/ml in PBS), again washed in 0.1 M PBS, and blocked/
permeabilized in PBS with 0.3% Triton X-100 (Sigma-Aldrich) and 5%
donkey serum (Sigma-Aldrich). Sections were then incubated overnight
in blocking solution with rabbit anti-GABA and goat anti-orx-B. On Day
2, tissue was washed in 0.1 M PBS, incubated in secondary antibodies for
2 h, washed in PBS, and mounted on microscope slides and coverslipped.
Digital images were captured with a Zeiss Axioskop 2 microscope and
QImaging QICAM Fast digital camera. Images were merged using Im-
ageJ (National Institutes of Health). Expression was analyzed separately
and subsequently merged and counted manually.
Results
Artificially applied orexin/hypocretin excites a minor part of
the MCH network
To explore OH peptide effects on MCH network, we first targeted
genetically encoded calcium indicators selectively to MCH neu-
rons in MCH-cre transgenic mice (see Materials and Methods;
Fig. 1A). This allows monitoring of neuronal excitation by using
cytosolic calcium concentration as a proxy (Chen et al., 2013). In
this assay, 30% of MCH neurons were activated by 1 M bath-
applied orexin-A; the rest were either unaffected or inhibited
(Fig. 1A). Second, we performed whole-cell current-clamp re-
cordings, where bath application of 1 M orexin-A also had
mixed effects on MCH cell membrane potential: some MCH
neurons slightly depolarized, but others were hyperpolarized or
did not respond (2/6 and 4/6 cells, respectively; Fig. 1B). These
results are consistent with previous work showing that some
MCH neurons can be activated by 1 M artificially applied orexin
(van den Pol et al., 2004; Li and van den Pol, 2006), but our data
suggest that this activation occurs in a minority of MCH cells.
Firing of OH neurons exerts inhibitory effects on MCH cell
membrane potential
Artificial application of neurotransmitters involves arbitrarily
chosen concentrations that may not correspond to those in native
neural networks, potentially creating unnatural responses (e.g.,
due to receptor desensitization). To examine intrinsic signals
generated by OH cell firing in MCH neurons, we performed op-
togenetic analysis of functional connectivity in LH brain slices.
To selectively stimulate OH cells while recording from identified
MCH cells, we expressed light-activated excitatory ion channel
ChR2 in OH neurons and simultaneously transduced MCH neu-
rons using lentiviral vector expressing the mCherry fluorescent
protein driven by an MCH gene promoter (Fig. 2A; see Materials
and Methods). Following stereotaxic injections of the mCherry-
MCH lentiviruses into the LH, mCherry-labeled neurons were
Figure 2. Membrane potential effects in MCH neurons of activation of intrinsic OH neurons. A, Targeted expression of mCherry in MCH neurons (n  3 animals, 630/638 mCherry cells colocalised
with MCH). Scale bars: top, 200 m; inset, 40 m. B, Whole-cell recordings in mCherry-expressing neurons (B2) were confirmed by filling neurons with biocytin (B3, B4 ). Membrane potential
responses to current injections (B5); n  50 cells. C, Effect of optogenetic stimulation of OH neurons. Typical example (C1) and summary of effects of different stimulation frequencies and drug
conditions on firing rate, normalized to prestimulation firing (C2); n  7 cells, two-way ANOVA, F(2,42)  21.37, Bonferroni post-test; ***p  0.001; ns, nonsignificant ( p  0.05).
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found only in the previously reported locations of MCH neurons
(the Zona Incerta, Lateral and Dorsomedial Hypothalamus; Fig.
2A,B1). MCH-like immunoreactivity was found in 98.7% of
mCherry-labeled cells (Fig. 2A; statistics for data shown in the
figures are reported in figure legends). Whole-cell recordings
from the mCherry cells (Fig. 2B5) revealed typical membrane
potential “signatures” of MCH cells (Burdakov et al., 2005), con-
firming that MCH cell function was unperturbed by the viral
infection. The firing of most MCH-mCherry cells was rapidly
reduced when OH-ChR2 cells were optically paced at a frequency
that we previously found to cause awakening in vivo (20 Hz;
Adamantidis et al., 2007; Fig. 2C; n  25/32 cells; note that this
represents 	80% of MCH cells with only 	40% of OH cells
transfected with ChR2 in our preparation; Schöne et al., 2012).
Lower optical stimulation frequencies were less effective (Fig.
2C2), mirroring stimulation requirement for OH peptide release
in slices (Schöne et al., 2014). Dynorphin is coexpressed in OH
neurons (Muschamp et al., 2014), and extrinsic application of
dynorphin can inhibit MCH neurons via -opiod receptors (Li
and van den Pol, 2006). However, the -opiod receptor antago-
nist Nor-BNI did not affect the inhibition of MCH activity by OH
cell firing (Fig. 2C2). In contrast, the OH ¡ MCH inhibition was
largely abolished by 10 M gabazine, a GABAA receptor blocker,
suggesting that it is mediated by local GABA release (Fig. 2C2).
OH cell firing controls GABA input to MCH cells via
OH receptors
To further investigate synaptic currents underlying the GABAe-
rgic suppression of MCH cell activity during OH cell firing, we
performed voltage-clamp recordings (at 80 mV) in glutamate
receptor blockers (CNQX
AP5). Optical stimulation signifi-
cantly increased the frequency of gabazine-sensitive IPSCs (Fig.
3A). IPSC frequency increased progressively during optical stim-
ulation (Fig. 3A2), similar to actions of OH peptides expected to
be released by this stimulation (Schöne et al., 2014). Application
of OH receptor antagonists substantially reduced the ability of
the optical stimulation to increase GABAergic tone (Fig. 3A). In
contrast, -opiod receptor antagonist did not affect the IPSC
stimulation (Fig. 3A2,3). If our optical stimulation increases
GABA input to MCH cells by releasing endogenous OH peptides,
then the increase in GABAergic tone should be mimicked by
artificially applied OH peptides. Indeed, bath-applied OH pep-
tide significantly increased the frequency of miniature GABAA-
mediated IPSCs (Fig. 3B).
Interestingly, in some cases we observed GABAA-mediated
IPSCs in MCH neurons that appeared time-locked (2–10 ms
latency) to the optical flashes stimulating OH neurons (Fig.
4A). The probability of the short-latency (10 ms) IPSCs was
also increased by bath-applied OH peptide (Fig. 4A3). It has
been suggested that latencies 1.8 ms may represent indirect,
polysynaptic connections (Gil and Amitai, 1996). Thus, our
latencies could mean that OH neurons fire GABA interneu-
rons projecting to MCH cells, presumably by releasing OH
peptide since the responses persisted in glutamate receptor
blockers (Fig. 4A1). Alternatively, due to delays between opti-
cal flashes and the spikes they evoke in ChR2-expressing cells
(Tecuapetla et al., 2010), it cannot be excluded that some OH
cells may release GABA onto MCH cells. Indeed, it has been
previously hypothesized based on immunocytochemistry,
real-time PCR, and electron-microscopy that a subgroup of
Figure 3. Membrane current effects in MCH neurons of activating intrinsic OH neurons, and of bath-applied OH peptide. A1, Typical example of MCH cell IPSCs caused by optical stimulation of OH
cells (n  26 cells). IPSCs were recorded in the presence of CNQX/AP5, and confirmed as GABAergic by blockade with gabazine. A2, Summary of effects of OH cell stimulation on MCH cell IPSC tone,
under different drug conditions (n  26 cells). A3, Comparison of IPSC tone at different times relative to the optical stimulation (6 s before, last 6 s of stimulation, and 6 s after the stimulation). Color
codes and data are the same as in A2. Two-way ANOVA, F(2,42)  21.37, Bonferroni post-test: ***p  0.001; *p  0.05; ns, nonsignificant ( p  0.05). B1, Typical example of effect of bath applied
orexin-A on miniature IPSCs (n  5 cells). B2, Comparison of miniature IPSC frequency with and without bath orexin; n  5 cells, Kolmogorov–Smirnov test, p  0.001.
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OH cells may release GABA (Guan et al., 2002; Harthoorn et
al., 2005; Balcita-Pedicino and Sesack, 2007). We confirmed
that GABA-like immunoreactivity is present in a subpopula-
tion of OH neurons (10 –25% of OH cells, depending on LH
area; Fig. 4B, but see Discussion).
At least some MCH cells are GABAergic (Jego et al., 2013), and
some may be excited by OH neurons (Fig. 1A1; Guan et al., 2002;
van den Pol et al., 2004; Li and van den Pol, 2006). This suggests
a possibility that some of OH-dependent GABA drive to MCH
neurons may come from other MCH neurons. To test this, we
performed dual whole-cell recordings from identified MCH-
mCherry cell pairs (Fig. 4C). We generated action potentials in
one MCH cell, while recording synaptic responses in another
MCH cell. We did not find evidence of MCH-to-MCH functional
connectivity: presynaptic action potentials did not generate de-
tectable postsynaptic responses in 43 MCH-MCH cell pairs tested
(Fig. 4C).
Discussion
A key question in systems neuroscience is how the brain ensures
that opposing signals, such those causing sleep and wake transi-
tions, are scheduled to occur at separate times. Inappropriate
co-occurrence of such signals can produce pathological brain
states and behaviors, for example concurrent wakefulness and
sleep-paralysis (Dauvilliers et al., 2007). Our results provide a
network-level explanation for how such pathological mixing of
opposing neural drives may be prevented by natural LH micro-
circuits. Our data suggest that when OH neurons fire at rates that
promote awakening (Adamantidis et al., 2007), the spike output
of most MCH neurons is suppressed, due to increased GABAer-
gic drive into those cells (Fig. 2C). The GABAergic inhibition of
MCH cells depends significantly on OH receptors, whereas glu-
tamate receptors are not essential (Fig. 3A2). This is consistent
with our previous data that OH (but not glutamate) transmission
is critical for translating OH cell firing into sustained postsynap-
tic electrical responses (Schöne et al., 2014). Our data are also
consistent with the possibility that OH may release GABA them-
selves (Fig. 4). However, further molecular and ultra-structural
data would be necessary to ascertain how OH cells may produce
GABA and/or package it into vesicles, because the GABA staining
we observed may be cytosolic (and not vesicular), and we found
no evidence of OH immunoreactivity in vgat-positive neurons of
the LH (D. Burdakov and J. Apergis-Schoute, unpublished ob-
servations). It remains to be determined whether OH neurons
may acquire GABAergic functional identity through noncanoni-
cal transporters, such as recently reported for dopamine neurons
(Tritsch et al., 2012, 2014).
Figure 4. Inhibitory actions and GABA content of OH neurons. A1, An example of a short-latency (10 ms) IPSC evoked by a blue laser flashes (n  7 cells). A2, distribution of short latencies (A2;
n  48 cells). A3, effect on bath-applied orexin-A on short-latency IPSC recorded as in A1 (n  5 cells). Paired two-tailed Student’s t test, **p  0.005, *p  0.05; ns, nonsignificant ( p  0.05).
B, Orexin-containing neurons immunopositive for GABA (B1) are distributed throughout hypothalamic subregions. The number of OH-immunopositive cells colocalized with GABA were as follows:
LH, 107/590; perifornical area (PeF), 23/88; dorsomedial hypothalamus (DMH), 29/226; total 159/908 cells (n  3 brains; B2). Scale bar, 40 m. C, Schematic (C1) and live brain-slice image (C2)
of paired recordings from MCH-mCherry neurons. Scale bar, 50 m. C3, representative recordings from an MCH-MCH cell pair, showing that evoked action potentials in one cell did not produce
postsynaptic current in the other. Black lines are individual traces and green/blue are averaged traces. Current-clamp protocol used to evoke action potentials is shown below the traces. Similar
results were obtained from 43 cell pairs.
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More broadly, our results offer a reconciliation for the appar-
ent contradictions in existing in vitro and in vivo data on relative
timing of OH and MCH cell activity (van den Pol et al., 2004;
Hassani et al., 2009). Although we observed only inhibitory ef-
fects during intrinsic OH cell ¡ MCH cell actions (consistent
with Hassani et al., 2009), our data with bath applications of OH
peptide suggested that it may also directly excite some MCH
neurons (consistent with van den Pol et al., 2004). It is possible
that the high levels of OH peptide required to excite MCH cells
are not attained during optogenetic stimulation in slices or dur-
ing acute experiments. In vivo, during overexcitation of OH cells,
it remains possible that OH peptides may reach high-enough
levels to excite MCH cells directly, which may provide a feedback
mechanism preventing hyperarousal. In terms of natural drives
of OH neurons, there is evidence that noradrenaline input to OH
cells may switch sign after sleep deprivation due to a switch in
receptor type (Grivel et al., 2005; Uschakov et al., 2011). This
suggests the coupling of MCH cell activity to arousal state in
general, and to noradrenaline drive in particular, may change as a
function of stress or sleep pressure, an interesting possibility that
deserves future investigation.
We predict that the OH receptor-dependent intrinsic OH ¡
MCH inhibitory signaling (Fig. 3A2) is mediated by local OH-
excited GABA neurons. It would be important to determine the
identities of these neurons in future investigations, and our
paired recordings (Fig. 4C) currently suggest that these GABA
cells may be separate from MCH neurons themselves. At the level
of local circuits in the LH, our data provide functional experi-
mental support for the “flip-flop” model of binary switching be-
tween sleep and wake signals (Saper et al., 2005). The GABAergic
microcircuits mediating OH ¡ MCH cell inhibition may consti-
tute a new therapeutic target, because they are likely to oppose the
pathological mixing of sleep and wake states in disorders such as
narcopelsy.
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